ArticlePDF Available

Serological survey of SARS‐CoV‐2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals

Wiley
Transboundary and Emerging Diseases
Authors:
  • Pulike biological engineering, INC.

Abstract

The pandemic SARS‐CoV‐2 has been reported in 123 countries with more than 5000 patients died from it. However, the original and intermediate hosts of the virus remain unknown. In this study, 1914 serum samples from 35 animal species were used for detection SARS‐CoV‐2 specific antibodies using double antigen sandwich ELISA after validating its specificity and sensitivity. The results showed that no SARS‐CoV‐2 specific antibodies were detected in above samples which excluded the possibility of 35 animal species as intermediate host for SARS‐CoV‐2. More importantly, companion animals including pet dogs (including one dog the SARS‐CoV‐2 patient kept and two dogs which had close contact with it) and cats, street dogs and cats also showed serological negative to SARS‐CoV‐2, which relieved the public concerns for the pets as SARS‐CoV‐2 carriers.
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/TBED.13577
This article is protected by copyright. All rights reserved
DR. KEGONG TIAN (Orcid ID : 0000-0001-5362-1415)
Article type : Short Communication
Short Communication
Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals
excludes intermediate hosts of 35 different species of animals
Junhua Deng1, Yipeng Jin3, Yuxiu Liu2, Jie Sun2, Liying Hao2, Jingjing Bai2,
Tian Huang2, Degui Lin3, Yaping Jin1*, Kegong Tian2*
1College of veterinary medicine, Northwest A&F University, Yangling 712100,
2National Research Center for Veterinary Medicine, Luoyang 471003
3College of Veterinary Medicine, China Agricultural University, Beijing, 100193
*Corresponding authors: Profs. Yaping Jin and Kegong Tian
E-mail: yapingjin@163.com, tiankg@263.net
Running tittle: SARS-CoV-2 serological survey in 35 animal species
Abstract: The pandemic SARS-CoV-2 has been reported in 123 countries with more than 5000
patients died from it. However, the original and intermediate hosts of the virus remain unknown.
In this study, 1914 serum samples from 35 animal species were used for detection SARS-CoV-2
specific antibodies using double antigen sandwich ELISA after validating its specificity and
sensitivity. The results showed that no SARS-CoV-2 specific antibodies were detected in above
samples which excluded the possibility of 35 animal species as intermediate host for
Accepted Article
This article is protected by copyright. All rights reserved
SARS-CoV-2. More importantly, companion animals including pet dogs (including one dog the
SARS-CoV-2 patient kept and two dogs which had close contact with it) and cats, street dogs and
cats also showed serological negative to SARS-CoV-2, which relieved the public concerns for the
pets as SARS-CoV-2 carriers.
Key words: SARS-CoV-2, Intermediate hosts, Wild animals
Introduction
SARS-CoV-2, previously was named as COVID-2019 by the WHO, is now pandemic which
has been reported 5077 human death of 136895 confirmed cases in 123 countries (updated on
March 14, 2020 from WHO official website). The viruses have been successfully isolated, but the
pathogenesis mechanisms and effective vaccines are undergoing extensively study. SARS-CoV-2
belongs to Betacoronavirus genera in the subfamily Orthocoronavirinae of family Coronaviridae,
in which SARS-CoV and MERS-CoV are also in this group. The natural host of highly pathogenic
SARS and MERS coronaviruses was confirmed as bats, and bats are also thought to be the natural
hosts for SARS-CoV-2 based upon genomic sequence analysis (Wang et al., 2020). Coronaviruses
needed intermediate hosts before being able to infect humans. Masked palm civets and dromedary
camels were confirmed as intermediate hosts for SARS CoV and MERS CoV (Guarner, 2020), but
the intermediate hosts remain unknown for SARS-CoV-2 (Ward et al., 2020).
In order to find the intermediate host of SARS-CoV-2, a commercial double antigen sandwich
ELISA, which could be applied for different species of animals, was used to detect SARS-CoV-2
specific antibodies in different species of animals. Before applied to clinical serum samples, the
sensitivity and specificity of kit was initially confirmed using SARS-CoV-2 positive and negative
sera from experimental animals including rabbit, mouse, pig, and ferret. SARS-CoV-2 negative
sera from other species of experimental animals were also used which included chicken, duck, rat,
guinea pig, beagle dog, and rhesus monkey. After that, the kit was used to detect SARS-CoV-2
specific antibodies in domestic livestock (pig, cow, sheep, horse), poultry (chicken, duck, goose),
experimental animals (mice, rat, guinea pig, rabbit, and monkey), companion animal (dog and cat),
Accepted Article
This article is protected by copyright. All rights reserved
and wild animals (camel, fox, mink, alpaca, ferret, bamboo rat, peacock, eagle, tiger rhinoceros,
pangolin, leopard cat, jackal, giant panda, masked civet, porcupine, bear, yellow-throated marten,
weasel, red pandas, and wild boar). The results showed that no SARS-CoV-2 specific antibodies
were detected in above species of animals including pangolin which has been reported as an
intermediate host of SARS-CoV-2 (Kangpeng Xiao, 2020). More importantly, we found
companion animals including dogs and cats were serologically negative to SARS-CoV-2 including
one dog kept by the SARS-CoV-2 patient and two dogs with close contact with it during the
quarantine.
Materials and methods
The SARS-CoV-2 double antigen sandwich ELISA were purchased from Luoyang Putai
Biotechnology Co., Ltd (Luoyang, China). The coating was based on S1 protein of SARS-CoV-2.
The same antigen was linked to horseradish peroxidase (HRP) to function as conjugate. The serum
samples were test as the manufacture manual instructions. Briefly, 100µl serum sample was added
into each well of ELISA plate and incubated at 37°C for 30 min. After washing the plate with
washing buffer for 5 times, HRP-labeled antigen was added into the wells at 37°C for 30 min
before 100μl of the substrate solution was added to each well and incubated at 37°C for 10 min to
stop the reaction. The optical density (OD) was measured at 450 nm. The final value of OD450 of
sample = the value of OD450 readout of sample - the value of OD450 of blank control. The cutoff
was set as 0.26 + the mean value of OD450 of negative controls.
The serum samples of chicken, duck, mouse, rat and pig were preserved in our laboratory. The
ferret SARS-CoV-2 positive and negative serum samples were provided by Harbin Veterinary
Research Institute, Chinese Academy of Agricultural Sciences. The ferrets (3-month old) were
infected with 1.2 mL SARS-CoV-2 (1×105TCID50/ml) by intranasal infection in ABSL-3 facility.
The infected ferrets were bled at 0, 7, 12, 17 and 22 dpi and euthanized at 22dpi. The serum
samples were collected and inactivated before use. The positive sera for other different
coronaviruses were also used in this study. The positive serum samples for porcine epidemic
diarrhea virus (PEDV), porcine transmissible gastroenteritis virus (TGEV), porcine
Accepted Article
This article is protected by copyright. All rights reserved
deltacoronavirus (PDCoV) were made by immunization of SPF pigs with the corresponding virus,
respectively. The positive serum samples for infectious bronchitis virus (IBV) was immunization
of SPF chickens with the virus. Positive sera for mouse hepatitis virus (MHV) and rat corona virus
(RCV) were made by infection of SPF mice and rats by MHV and RCV, respectively. The rest of
serum samples from different species were collected from November 2019 to March 2020 and
kept in our laboratory. All samples were collected in compliance with fundamental ethical
principles. The numbers of different animal species used in this study were shown in the brackets
below.
Results and discussion
To test the specificity of ELISA kit, the serum samples of SPF chicken (28), duck (25), mouse
(23), rat (20) and pig (20) were applied. The final value of OD450 of samples ranged from 0.005 to
0.103 (median 0.007), 0.004 to 0.008 (median 0.006), 0.005 to 0.190 (median 0.007), 0.004 to
0.050 (median 0.007), 0.005 to 0.134 (median 0.007) for chicken, duck, mouse, rat and pig,
respectively. Serum samples from other species of experimental animals including guinea pig (30),
rabbits (34), beagle dogs (130), rhesus monkeys (38) were also tested. There were no
SARS-CoV-2 antibodies detected in above animals (data not shown). Next, the potential
cross-reaction with other coronavirus including IBV (26), PEDV (24), TGEV (20), PDCoV (20),
MHV (20) and RCV (20) were tested with corresponding positive serum samples. The final value
of OD450 of samples ranged from 0.004 to 0.134 (median 0.007), 0.005 to 0.022 (median 0.007),
0.007 to 0.071(median 0.018), 0.005 to 0.040 (median 0.010), 0.004 to 0.061(median 0.006),
0.005 to 0.064 (median 0.009) for IBV, PEDV, TGEV, PDCoV, MHV and RCV, respectively.
The above results showed that the SARS-CoV-2 ELISA has good specificity without
cross-reaction with other coronaviruses from different animal species.
We next tested the sensitivity of ELISA kit. The SARS-CoV-2 experimental-infected ferret
positive sera were tested. As shown in Table1, the neutralizing antibody titers of 5 infected ferret
(F1-F5) were between 1:128 and 1:256 at 22 days post-infection (dpi). By contrast, the
neutralizing antibody titers of 5 placebo ferrets (C1-C5) were all negative at 22 dpi. In the line
Accepted Article
This article is protected by copyright. All rights reserved
with the results of neutralizing antibodies, the final OD450 of 5 positive sera detected by ELISA
were all above 3, which indicated strongly serological positive to SARS-CoV-2. To further test the
dynamic changes of ELISA titer of infected ferret, serum samples from one ferret were collected
from 0, 7, 12, 17, 22dpi, respectively. The positive ELISA results were shown at 7dpi and lasted
until 22dpi when the ferrets were humanely euthanized (Table1). The above results showed that
the ELISA has good specificity and sensitivity and suitable for different species of animals.
After confirming the specificity, sensitivity and suitability of SARS-CoV-2 ELISA kit for
different species of experimental animals, clinical serum samples from domestic livestock (pig,
cow, sheep, horse), poultry (chicken, duck, goose), experimental animal (mice, rat, and rhesus
monkey), companion animal (dog and cat), and wild animals (camel, fox, mink, alpaca, ferret,
bamboo rat, peacock, eagle, tiger rhinoceros, pangolin, leopard cat, jackal, giant panda, masked
civet, porcupine, bear, yellow-throated marten, weasel, red pandas, and wild boar). were used for
antibody detection. As shown in Table2, all serum samples had negative results which excludes
the above animal species as intermediate host of SARS-CoV-2. Real-time PCR with specific
primers and probe for SARS-CoV-2 recommended by Chinese Center for Disease Control and
Prevention was also performed for parts of serum samples including the dog kept by confirmed
SARS-CoV-2 patient and two dogs with close contact with it, and the results were negative (data
not shown). Of note, no SARS CoV-2 specific antibodies were detected in all dogs and cats, even
for the street dogs and cats in Wuhan City and the pet dog raised by SARS CoV-2 patient.
So far, seven coronaviruses were confirmed infection of human including SARS CoV, MERS
CoV, HCoV NL63, HCoV 229E, HCoV OC43, HKU1 and SARS-CoV-2. Bat was deemed to be
the natural host for SARS CoV, MERS CoV, HCoV NL63 and HCoV 229E, and rodents for
HCoV OC43 and HKU1(Khan et al., 2020). The intermediate hosts for SARS CoV, MERS CoV,
HCoV 229E, and HCoV OC43 were found to be palm civets, dromedary camels, alpacas and
cattle, respectively. However, the natural and intermediate hosts SARS-CoV-2 remain unknown.
Since SARS-CoV-2 is genetically close to SARS-CoV, it has been proposed that bat could be the
natural host (Phan, 2020). Snake is also presumed as wildlife animal reservoir for SARS-CoV-2
based on the virus relative synonymous codon usage (RSCU) bias (Ji et al., 2020). However, there
Accepted Article
This article is protected by copyright. All rights reserved
is no report of SARS-CoV-2 isolation or molecular and serological confirmation of infection from
snake samples. Pangolins recently was suggested to be direct animal source of SARS-CoV-2 for
humans since the SARS-CoV-2 related coronaviruses were isolated from Malayan pangolins
which shared 97.4% similarity with SARS-CoV-2 in virus receptor binding domain in S gene
(Kangpeng Xiao, 2020). In our study, we did not detect SARS-CoV-2 antibodies in 17 pangolin
serum samples. Consistent with our results, Li X, et al reported the coronavirus carried by
pangolins did not have the RRAR motif, a unique peptide insertion in the human SARS-CoV-2
virus (Li et al., 2020). The RRAR motif may be involved in the proteolytic cleavage of spike
protein and host range and transmissibility which suggests human SARS-CoV-2 virus did not
come directly from pangolins (Li et al., 2020). Masked civet and camel were confirmed to be
natural hosts for SARS-CoV and MERS-CoV, no specific SARS-CoV-2 antibodies were detected
in 10 masked civets and 31 camels in this study.
The susceptibility of companion animals including cats and dogs to the SARS-CoV-2 has been
major concern for the public. One pet dog was reported to be SARS-CoV-2 positive detected by
RT-PCR in Hongkong (https://www.news.gov.hk/eng/2020/02/
20200228/20200228_093205_796.html). Later, the serological result of the dog showed negative
after quarantine of 14 days. In our study, 87 cats including 66 pet cats and 21 street cats showed
serological negative to SARS-CoV-2 (Table2). At the same time, 487 dogs including 90 beagle
dogs, 147 pet dogs and 250 street dogs during the outbreak of SARS-CoV-2 were also tested
serological negative. Among them, 15 pet dog and 99 street dog sera were collected from Wuhan
City. It should be noted that, one pet dog from confirmed SARS-CoV-2 infected patient showed
serologically negative, and other two dogs which had close contact with this dog also tested to be
negative. However, we cannot rule out of susceptibility of cats and dogs to SARS-CoV-2, which
need to be tested by experimental infections.
Molecular techniques such as reverse-transcriptase PCR tests and viral genome sequencing are
widely used for the confirmation of human infection. These techniques are also used to explore the
potential hosts of SARS-CoV-2 (Pfefferle et al., 2020). Compared to these molecular methods,
serological test such as ELISA has several advantages. First, the host generates SARS-CoV-2
Accepted Article
This article is protected by copyright. All rights reserved
specific antibodies after infection which could last longer than the viremia. It provides a wider
detection window for ELISA than RT-PCR. Second, RNA extraction from susceptive infected
samples has to be performed in a BSL-3 laboratory. By contrast, ELISA can be performed in a
safety level 2 laboratory and does not require high containment facilities after the serum samples
were inactivated at 56°C for 30 min. Third, double antigen sandwich ELISA based on
recombinant S1 protein could detect both IgM and IgG antibodies and is not limited to species. To
find the host of SARS-CoV-2, the screening of other wild animals using ELISA in undergoing in
our laboratory.
Acknowledgments
We want to thank Dr. Zhigao Bu, Director of Harbin Veterinary Research Institute, Chinese
Academy of Agricultural Sciences for providing inactivated SARS-CoV-2 negative and positive
ferret serum samples. This study was supported by Luoyang Heluo Talent Plan (Kegong Tian).
Conflict of interest statement
There was no conflict of interest with others.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon
reasonable request.
Ethical Statement
We declare that Ethical Statement is not applicable.
Reference
Guarner, J., 2020: Three Emerging Coronaviruses in Two Decades. American journal of clinical
pathology, 153, 420-421.
Ji, W., W. Wang, X. Zhao, J. Zai and X. Li, 2020: Cross-species transmission of the newly
identified coronavirus 2019-nCoV. Journal of medical virology, 92, 433-440.
Kangpeng Xiao, J. Z., Yaoyu Feng, Niu Zhou, Xu Zhang, Jie-Jian Zou, Na Li, Yaqiong Guo,
Accepted Article
This article is protected by copyright. All rights reserved
Xiaobing Li, Xuejuan Shen, Zhipeng Zhang, Fanfan Shu, Wanyi Huang, Yu Li, Ziding
Zhang, Rui-Ai Chen, Ya-Jiang Wu, Shi-Ming Peng, Mian Huang, Wei-Jun Xie, Qin-Hui
Cai, Fang-Hui Hou, Yahong Liu, Wu Chen, Lihua Xiao, Yongyi Shen, 2020: Isolation and
Characterization of 2019-nCoV-like Coronavirus from Malayan Pangolins. BioRxiv.
Khan, S., R. Siddique, M. A. Shereen, A. Ali, J. Liu, Q. Bai, N. Bashir and M. Xue, 2020: The
emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.
Journal of clinical microbiology.
Li, X., J. Zai, Q. Zhao, Q. Nie, Y. Li, B. T. Foley and A. Chaillon, 2020: Evolutionary history,
potential intermediate animal host, and cross-species analyses of SARS-CoV-2. Journal of
medical virology.
Pfefferle, S., S. Reucher, D. Norz and M. Lutgehetmann, 2020: Evaluation of a quantitative
RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high
throughput system. Euro surveillance : bulletin Europeen sur les maladies transmissibles
= European communicable disease bulletin, 25.
Phan, T., 2020: Genetic diversity and evolution of SARS-CoV-2. Infection, genetics and
evolution : journal of molecular epidemiology and evolutionary genetics in infectious
diseases, 81, 104260.
Wang, C., P. W. Horby, F. G. Hayden and G. F. Gao, 2020: A novel coronavirus outbreak of
global health concern. Lancet, 395, 470-473.
Ward, M. P., X. Li and K. Tian, 2020: Novel coronavirus 2019, an emerging public health
emergency. Transboundary and emerging diseases, 67, 469-470.
Table Legends
Table1. ELISA and neutralizing antibody titer results of ferret sera.
Accepted Article
This article is protected by copyright. All rights reserved
F1 (0 dpi)
0.007
-
2
-
F1 (7 dpi)
0.841
+
16
+
F1 (12 dpi)
1.301
+
32
+
F1 (17 dpi)
3.477
+
128
+
F1 (22 dpi)
3.234
+
128
+
F2 (22 dpi)
3.023
+
256
+
F3 (22 dpi)
3.444
+
256
+
F4 (22 dpi)
3.5
+
256
+
F5 (22 dpi)
3.332
+
256
+
C1 (0 dpi)
0.022
-
<2
-
C2 (0 dpi)
0.014
-
<2
-
C3 (0 dpi)
0.009
-
<2
-
C4 (0 dpi)
0.013
-
<2
-
C5 (0 dpi)
0.025
-
<2
-
C1 (22 dpi)
0.021
-
<2
-
C2 (22 dpi)
0.027
-
<2
-
C3 (22dpi)
0.018
-
<2
-
C4 (22 dpi)
0.005
-
<2
-
Ferret
C5 (22dpi)
0.011
-
<2
-
*The neutralizing antibody titer of positive samples were 4. dpi: days post-infection.
Accepted Article
Animal
species
Serum
sample ID
Final OD450
Results
Neutralizing
antibody titer *
Results
This article is protected by copyright. All rights reserved
Table2. Summary of ELISA antibody titer results of 35 animal species.
 
Animal species
Minimum of
ELISA readout
Maximum of
ELISA
readout
Median of
ELISA
readout
Pig1
0.005
0.134
0.007
Cow
0.002
0.18
0.007
Sheep
0.002
0.169
0.01
Domestic
Animals (4)
Horse
0.002
0.189
0.011
Chicken2
0.005
0.134
0.006
Duck3
0.004
0.189
0.007
Poultry (3)
Goose
0.005
0.121
0.005
Mice4
0.004
0.19
0.006
Rat5
0.004
0.095
0.008
Guinea pig6
0.005
0.031
0.008
Rabbit7
0.005
0.029
0.006
Monkey8
0.001
0.141
0.011
Experimental
and
companion
animals (7)
Dog9
0.004
0.198
0.007
Accepted Article
This article is protected by copyright. All rights reserved
Cat10
0.005
0.045
0.007
Camel
0.005
0.178
0.008
Fox
0.005
0.197
0.009
Mink
0.001
0.195
0.008
Alpaca
0.004
0.02
0.006
Ferret
0.036
0.038
0.037
Bamboo rat
0.005
0.008
0.006
Peacock
0.006
0.009
0.007
Eagle
0.0066
0.0066
0.0066
Tiger
0.004
0.077
0.005
Rhinoceros
0.005
0.006
0.005
Pangolin
0.004
0.156
0.006
Leopard cat
0.005
0.007
0.005
Jackal
0.01
0.01
0.01
Giant panda
0.005
0.05
0.007
Masked civet
0.004
0.014
0.006
Porcupine
0.007
0.007
0.007
Bear
0.005
0.006
0.006
Yellow-throate
d marten
0.005
0.095
0.008
Weasel
0.006
0.006
0.006
Red pandas
0.005
0.005
0.005
Wild animals
(21)
Wild boar
0.005
0.005
0.005
Note: All above results were negative. 1Including 20 SPF pigs. 2Including 28 SPF chickens. 3Including 25 SPF
ducks.4Including 23 SPF mice.5Including 20 SPF rats. 6Experimental animals. 7Experimental animals.8Including 38
rhesus monkey and one wild Ruffed lemur. 9Including 90 beagle dogs, 250 street dogs, and 147 pet dogs. Fifteen pet
dog and 99 street dog sera were collected from Wuhan City. 10Including 66 pet cats and 21 street cats.
Accepted Article
... Likewise, ELISA was used to detect SARS-CoV-2-specific antibodies in 1,914 serum samples from 35 animal species, including experimental, domestic, companion and wild animals (Deng et al. 2020). None of the samples tested positive for SARS-CoV-2 antibodies, suggesting that these animals were not exposed to or infected by SARS-CoV-2. ...
Article
Proteomics, the large-scale study of proteins in biological systems has emerged as a pivotal tool in the field of animal and veterinary sciences, mainly for investigating local and rustic breeds. Proteomics provides valuable insights into biological processes underlying animal growth, reproduction, health, and disease. In this review, we highlight the key proteomics technologies, methodologies, and their applications in domestic animals, particularly in the tropical context. We also discuss advances in proteomics research, including integration of multi-omics data, single-cell proteomics, and proteogenomics, all of which are promising for improving animal health, adaptation, welfare, and productivity. However, proteomics research in domestic animals faces challenges, such as sample preparation variation, data quality control, privacy and ethical considerations relating to animal welfare. We also provide recommendations for overcoming these challenges, emphasizing the importance of following best practices in sample preparation, data quality control, and ethical compliance. We therefore aim for this review to harness the full potential of proteomics in advancing our understanding of animal biology and ultimately improve animal health and productivity in local breeds of diverse animal species in a tropical context.
... It is also well known that sweat is not a classical way of virus excretion. Finally, the virus replicates very rarely in dogs (46), and only after prolonged and direct contact with a highly contagious patient. Therefore, the chance of viral transmission is minimal. ...
Article
Full-text available
Detection dogs were trained to detect SARS-CoV-2 infection based on armpit sweat odor. Sweat samples were collected using cotton pads under the armpits of negative and positive human patients, confirmed by qPCR, for periods of 15-30 min. Multiple hospitals and organizations throughout Belgium participated in this study. The sweat samples were stored at −20°C prior to being used for training purposes. Six dogs were trained under controlled atmosphere conditions for 2-3 months. After training, a 7-day validation period was conducted to assess the dogs' performances. The detection dogs exhibited an overall sensitivity of 81%, specificity of 98%, and an accuracy of 95%. After validation, training continued for 3 months, during which the dogs' performances remained the same. Gas chromatography/mass spectrometry (GC/MS) analysis revealed a unique sweat
Article
Full-text available
The emergence of the novel coronavirus SARS-CoV-2 has led to significant interest in its potential transmission between animals and humans, especially pets. This review article summarises the literature on coronavirus infections in domestic animals, emphasising epidemiology, transmission dynamics, clinical manifestations, and public health implications. This article highlights current understandings of the relationship between infections in companion animals and humans, identifies research gaps, and suggests directions for future research. Cases of disease in cats, dogs, and other domestic animals, often occurring through close contact with infected owners, are reviewed, raising concerns about possible zoonotic and reverse zoonotic transmission. Precautions and recommendations for pet owners and healthcare workers are also discussed. The scientific evidence presented in the article highlights the need for a One Health approach that considers the health of people, animals, and the environment to combat future pandemics.
Article
Full-text available
Many different animal species are susceptible to SARS-CoV-2, including a few Canidae (domestic dog and raccoon dog). So far, only experimental evidence is available concerning SARS-CoV-2 infections in red foxes (Vulpes vulpes). This is the first report of SARS-CoV-2 RNA detection in a sample from a red fox. The RT-qPCR-positive fox was zoo-kept together with another fox and two bears in the Swiss Canton of Zurich. Combined material from a conjunctival and nasal swab collected for canine distemper virus diagnostics tested positive for SARS-CoV-2 RNA with Ct values of 36.9 (E gene assay) and 35.7 (RdRp gene assay). The sample was analysed for SARS-CoV-2 within a research project testing residual routine diagnostic samples from different animal species submitted between spring 2020 and December 2022 to improve knowledge on SARS-CoV-2 infections within different animal species and investigate their potential role in a One Health context. Within this project, 246 samples from 153 different animals from Swiss zoos and other wild animal species all tested SARS-CoV-2 RT-qPCR and/or serologically negative so far, except for the reported fox. The source of SARS-CoV-2 in the fox is unknown. The fox disappeared within the naturally structured enclosure, and the cadaver was not found. No further control measures were undertaken.
Article
Full-text available
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in a zoological institution were initially reported in March 2020. Since then, at least 94 peer-reviewed cases have been reported in zoos worldwide. Among the affected animals, nonhuman primates, carnivores, and artiodactyls appear to be most susceptible to infection, with the Felidae family accounting for the largest number of reported cases. Clinical symptoms tend to be mild across taxa; although, certain species exhibit increased susceptibility to disease. A variety of diagnostic tools are available, allowing for initial diagnostics and for the monitoring of infectious risk. Whilst supportive therapy proves sufficient in most cases, monoclonal antibody therapy has emerged as a promising additional treatment option. Effective transmission of SARS-CoV-2 in some species raises concerns over potential spillover and the formation of reservoirs. The occurrence of SARS-CoV-2 in a variety of animal species may contribute to the emergence of variants of concern due to altered viral evolutionary constraints. Consequently, this review emphasizes the need for effective biosecurity measures and surveillance strategies to prevent and control SARS-CoV-2 infections in zoological institutions.
Article
Full-text available
Simple Summary COVID-19, an emerging infectious disease of possible animal origin due to SARS-CoV-2, which has caused a severe pandemic, has also affected some zoo animals. Since non-human primates are considered susceptible hosts, we tested 43 lemurs (20 black-and-white ruffed lemur Varecia variegata and 23 ring-tailed lemur Lemur catta) from a Spanish zoological institution, which were in close contact with humans during the pandemic period, for SARS-CoV-2 infection in both 2022 and 2023. We used molecular techniques for viral RNA detection in oropharyngeal and rectal swabs and blood anti-SARS-CoV-2 serology. The molecular assays were negative, but one animal was seropositive, strongly suggesting previous infection by SARS-CoV-2 of that animal. These data, while not pinpointing a high susceptibility of lemurs to SARS-CoV-2 infection, add to existing information on the need for surveillance of that virus in animals. Abstract In the setting of the recent COVID-19 pandemic, transmission of SARS-CoV-2 to animals has been reported in both domestic and wild animals and is a matter of concern. Given the genetic and functional similarities to humans, non-human primates merit particular attention. In the case of lemurs, generally considered endangered, they are believed to be susceptible to SARS-CoV-2 infection. We have conducted a study for evidence of SARS-CoV-2 infection among the 43 lemurs of Mundomar, a zoological park in Benidorm, Spain. They belong to two endangered lemur species, 23 black-and-white ruffed lemurs (Varecia variegata) and 20 ring-tailed lemurs (Lemur catta). Health assessments conducted in 2022 and 2023 included molecular analyses for SARS-CoV-2 RNA of oral and rectal swabs using two different RT-qPCR assays, always with negative results for SARS-CoV-2 in all animals. The assessment also included serological testing for antibodies against the receptor-binding domain (RBD) of the spike protein (S) of SARS-CoV-2, which again yielded negative results in all animals except one black-and-white ruffed lemur, supporting prior infection of that animal with SARS-CoV-2. Our data, while not indicating a high susceptibility of lemurs to SARS-CoV-2 infection, show that they can be infected, adding to the existing information body on potential ways for SARS-CoV-2 virus spreading in zoos, highlighting the need for animal surveillance for the virus.
Article
Full-text available
Adult horses are susceptible to equine coronavirus (ECoV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), although, only ECoV has been linked to clinical disease. Little information is available regarding the seroprevalence against ECoV and SARS-CoV-2 in adult healthy horses. The goal of the present study was to determine the seroprevalence against two coronaviruses known to infect horses using convenience samples collected from horses recently imported from Europe to the United States from 2019 to 2023. A total of 385 banked serum samples were tested against ECoV and SARS-CoV-2 using previously validated ELISA assays. Prevalence factors including date of arrival in the United States, signalment and country of origin were available for the majority of the horses. A total of 9/385 (2.3%) and 4/385 (1.0%) horses tested seropositive for ECoV and SARS-CoV-2, respectively. The ECoV seropositive horses were all mares, ages 4 to 26 years (median 9 years) and originated from Germany, the Netherlands, Ireland, Belgium and Italy. These mares were predominantly imported during the summer and fall months. All SARS-CoV-2 seropositive horses were mares ages 5 to 10 years (median 7.5 years) imported from the Netherlands and the United Kingdom. The majority of the SARS-CoV-2 seropositive horses were imported during the colder months of the year. The study results support the presence of ECoV in Europe and report on the first SARS-CoV-2 seropositive healthy adult horses outside the United States. Commingling for movements by air and close contact to humans may predispose transmission with ECoV and SARS-CoV-2, respectively.
Preprint
Full-text available
HKU4-related coronaviruses (CoVs) are merbecoviruses related to Middle Eastern Respiratory Syndrome coronavirus (MERS-CoV). In 2022 and 2023, two HKU4-related CoV strains were discovered in Manis javanica (Malayan pangolin) metagenomic datasets derived from organ samples: HKU4-P251T and MjHKU4r-CoV-1. Together with the Tylonycteris robustula bat CoV 162275, which was discovered in 2022, pangolin CoVs HKU4-P251T and MjHKU4r-CoV-1 form a novel phylogenetic clade distinct from all previously documented HKU4-related CoVs. In this study, we identified a novel HKU4-related CoV in a pangolin single-cell sequencing dataset generated by BGI-Shenzhen in Shenzhen, Guangdong, China in 2020. The CoV phylogenetically belongs to the same newly identified clade. The single cell datasets were reported as generated from organ samples of a single pangolin that died of natural causes. 98% of the HKU4-related CoV reads were found in only one of the seven single cell datasets -- a large intestine cell dataset, cells of which exhibit low expression of DPP4. Bacterial contamination was found to be moderately correlated with HKU4-related CoV presence. We further identified with high confidence that the RNA-Seq dataset supporting one of four near identical variants of MjHKU4r-CoV-1 is a Sus scrofa (wild pig) metagenomic dataset, with only a trace level of Manis javanica genomic content. The presence of HKU4-related CoV reads in the dataset are almost certainly laboratory research-related and not from a premortal pangolin or pig infection. Our findings raise concerns about the provenance of the novel HKU4-related CoV we identify here, MjHKU4r-CoV-1 and its four near-identical variants.
Article
Full-text available
The new decade of the 21 st century (2020) started with the emergence of novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans and mechanisms associated with the pathogenicity of SARS-CoV-2 are not clear yet, however, its resemblance with SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infected people. In this Review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2.
Article
Full-text available
Facing the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), high-volume respiratory testing is demanded in laboratories worldwide. We evaluated the performance of a molecular assay for the detection of SARS-CoV-2 on a high-throughput platform, the cobas 6800, using the 'open channel' for integration of a laboratory-developed assay. We observed good analytical performance in clinical specimens. The fully automated workflow enables high-throughput testing with minimal hands-on time, while offering fast and reliable results.
Article
Full-text available
To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed. To explore the potential intermediate animal host of the SARS‐CoV‐2 virus, we reanalyzed virome data sets from pangolins and representative SARS‐related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene. We performed phylogenetic, split network, transmission network, likelihood‐mapping, and comparative analyses of the genomes. Based on Bayesian time‐scaled phylogenetic analysis using the tip‐dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS‐CoV‐2, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 × 10⁻³ substitutions per site per year, respectively. Our results also revealed that the BetaCoV/bat/Yunnan/RaTG13/2013 virus was more similar to the SARS‐CoV‐2 virus than the coronavirus obtained from the two pangolin samples (SRR10168377 and SRR10168378). We also identified a unique peptide (PRRA) insertion in the human SARS‐CoV‐2 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility. Interestingly, the coronavirus carried by pangolins did not have the RRAR motif. Therefore, we concluded that the human SARS‐CoV‐2 virus, which is responsible for the recent outbreak of COVID‐19, did not come directly from pangolins. Highlights • We identified a unique peptide (PRRA) insertion in the human SARS‐CoV‐2 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility.
Preprint
Full-text available
The outbreak of 2019-nCoV in the central Chinese city of Wuhan at the end of 2019 poses unprecedent public health challenges to both China and the rest world. The new coronavirus shares high sequence identity to SARS-CoV and a newly identified bat coronavirus. While bats may be the reservoir host for various coronaviruses, whether 2019-nCoV has other hosts is still ambiguous. In this study, one coronavirus isolated from Malayan pangolins showed 100%, 98.2%, 96.7% and 90.4% amino acid identity with 2019-nCoV in the E, M, N and S genes, respectively. In particular, the receptor-binding domain of the S protein of the Pangolin-CoV is virtually identical to that of 2019-nCoV, with one amino acid difference. Comparison of available genomes suggests 2019-nCoV might have originated from the recombination of a Pangolin-CoV-like virus with a Bat-CoV-RaTG13-like virus. Infected pangolins showed clinical signs and histopathological changes, and the circulating antibodies reacted with the S protein of 2019-nCoV. The isolation of a coronavirus that is highly related to 2019-nCoV in the pangolins suggests that these animals have the potential to act as the intermediate host of 2019-nCoV. The newly identified coronavirus in the most-trafficked mammal could represent a continuous threat to public health if wildlife trade is not effectively controlled.
Article
COVID-19 is a viral respiratory illness caused by a new coronavirus called SARS-CoV-2. The World Health Organization declared the SARS-CoV-2 outbreak a global public health emergency. We performed genetic analyses of eighty-six complete or near-complete genomes of SARS-CoV-2 and revealed many mutations and deletions on coding and non-coding regions. These observations provided evidence of the genetic diversity and rapid evolution of this novel coronavirus.
Article
The current outbreak of viral pneumonia in the city of Wuhan, China, was caused by a novel coronavirus designated 2019‐nCoV by the World Health Organization, as determined by sequencing the viral RNA genome. Many initial patients were exposed to wildlife animals at the Huanan seafood wholesale market, where poultry, snake, bats, and other farm animals were also sold. To investigate possible virus reservoir, we have carried out comprehensive sequence analysis and comparison in conjunction with relative synonymous codon usage (RSCU) bias among different animal species based on the 2019‐nCoV sequence. Results obtained from our analyses suggest that the 2019‐nCoV may appear to be a recombinant virus between the bat coronavirus and an origin‐unknown coronavirus. The recombination may occurred within the viral spike glycoprotein, which recognizes a cell surface receptor. Additionally, our findings suggest that 2019‐nCoV has most similar genetic information with bat coronovirus and most similar codon usage bias with snake. Taken together, our results suggest that homologous recombination may occur and contribute to the 2019‐nCoV cross‐species transmission. Research Highlights • Taken together, our results suggest that homologous recombination may occur and contribute to the 2019‐nCoV cross‐species transmission.